Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Derace L. Schaffer currently holds 25,089 shares of PHARMATHENE, INC (PIP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Derace L. Schaffer has been a net seller of PIP stock. They have purchased $3.5M and sold $5.2M worth of shares.
Derace L. Schaffer's most recent insider trade was on Mar 3, 2020, when they sold 8,095 shares at $0.00 per share.
Derace L. Schaffer serves as Executive at PHARMATHENE, INC (PIP). They have executed 104 insider transactions totaling $8.6M over their tenure at the company.
Derace L. Schaffer holds the position of Executive at PHARMATHENE, INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Derace L. Schaffer has shown a selling trading pattern, with $3.5M in total purchases and $5.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Derace L. Schaffer was on Jun 5, 2019, when they sold $247.1K worth of LNTH shares. This transaction involved 10,000 shares at $24.71 per share.
Derace L. Schaffer currently owns 25,089 shares of PHARMATHENE, INC (PIP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Derace L. Schaffer's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Derace L. Schaffer has 104 Form 4 filings on record as an insider at PHARMATHENE, INC.
Set alerts for Derace L. Schaffer and 40,000+ other insiders.